Intravenous Vasodilator vs. Inotropic Therapy in Patients With Heart Failure
Status:
Withdrawn
Trial end date:
2018-06-01
Target enrollment:
Participant gender:
Summary
Single center, prospective, randomized, non-blinded research study comparing intravenous
vasodilator infusion vs. inotropic infusion in patients admitted to the hospital or in the
emergency room at Montefiore Medical Center presenting with the diagnosis of acute
decompensated systolic heart failure with low cardiac output but no hypotensive.